Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Assets (2022 - 2025)

NewGenIvf (NIVF) has disclosed Assets for 4 consecutive years, with $32.7 million as the latest value for Q4 2025.

  • Quarterly Assets rose 814.62% to $32.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.7 million through Dec 2025, up 814.62% year-over-year, with the annual reading at $32.7 million for FY2025, 814.62% up from the prior year.
  • Assets for Q4 2025 was $32.7 million at NewGenIvf, up from $3.6 million in the prior quarter.
  • The five-year high for Assets was $32.7 million in Q4 2025, with the low at $2.9 million in Q4 2022.
  • Average Assets over 4 years is $10.9 million, with a median of $4.0 million recorded in 2023.
  • The sharpest move saw Assets fell 20.26% in 2024, then soared 814.62% in 2025.
  • Over 4 years, Assets stood at $2.9 million in 2022, then soared by 54.46% to $4.5 million in 2023, then dropped by 20.26% to $3.6 million in 2024, then skyrocketed by 814.62% to $32.7 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $32.7 million, $3.6 million, and $4.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.